Recently, pathogenic phosphorylated tau has been discovered to disrupt nuclear‐cytoplasmic transport in AD through the binding of the nuclear pore protein, Nup98 (Eftekharzadeh et al., 2018; Lester & Parker, 2018). Here, MAPT is linked to Alzheimer disease.